Jon A Gothing - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Open Forum Infectious Diseases|January 29, 2021

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 VaccineesKarina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.

Blood|May 12, 2023

Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.

The Journal of Infectious Diseases|April 11, 2014

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.

The Journal of Infectious Diseases|April 19, 2018

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Open Forum Infectious Diseases|January 29, 2021

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 VaccineesKarina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.

Blood|May 12, 2023

Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donorsMichaël Desjardins, Phoebe Cunningham, Xhoi Mitre, et al.

The Journal of Infectious Diseases|April 11, 2014

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.

The Journal of Infectious Diseases|April 19, 2018

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.

Pageof 1